Catalyze Preclinical Services Program

The February Catalyze Webinar was held on February 22nd at 12:00 PM ET and featured Catalyze Scientific Director, Dr. Mike Pieck, announcing and describing a new suite of support services offered by the Catalyze Program. The Catalyze Preclinical Services Program is a new component of the Catalyze program which will support preclinical development activities from end-stage proof-of-concept, through preclinical development and US regulatory approval. In this presentation, Dr. Pieck will explain what the program seeks to accomplish in providing preclinical services, along with details of the application process. Time will be allotted for questions and answers.

Presenter: Dr. Mike Pieck, Catalyze Scientific Director

This seminar was presented on February 22, 2023 to an invited audience.

This video is for educational purposes only.

The Catalyze program utilizes a new approach to translational research by supporting both the technical needs of an innovation and the management, commercialization, regulatory, and training requirements of the innovators developing them. Projects supported by Catalyze receive funding and advisory support through the National Heart, Lung, and Blood Institute (NHLBI), as well as project management assistance, access to technical services and expertise, and training opportunities through the Catalyze Coordinating Center.

This research was funded, in part, by the National Institutes of Health (NIH) Agreement OT2 HL157844-01. The views and conclusions of the presenters are their own and should not be interpreted as representing the official policies, either expressed or implied, of the NIH.

NHLBI Catalyze Public Site: https://nhlbicatalyze.org

Presentation Bookmarks
0:00 Background
00:55 Catalyze Strategy
2:25 Program Components
3:15 Product Definition Funding Opportunities
3:17 Catalyze Coordinating Center Resources
4:33 Catalyze Preclinical Services Implementation 2023
6:15 Target Criteria for Preclinical Services Small Molecules
6:55 Target Criteria for Preclinical Services Biologics
7:38 Target Criteria for Preclinical Services Tissue Engineered Products
8:13 Target Criteria for Preclinical Services Devices
9:15 Technical Services Applications Process
11:00 Expression of Interest
12:17 Full Application – 30 day submission window
16:57 Expectations for Awardees
18:40 Full Application – Items to prepare now
20:10 NHLBI Catalyze Information
21:00 Q&A